Through the SOPHIE program, PreOperative Performance will enter a 12-month co-development partnership with The Research
Allarta Life Science leverages the SOPHIE program with the goal of licensing technology and commercializing treatments.
The Molecules and Masterpieces event showcased the SOPHIE program’s role as a catalyst for partnerships, commercialization and innovation services in the Hamilton life science sector.
Medtech company DiagnaMed leverages the SOPHIE program to accelerate commercialization timelines of CERVAI™, their novel brain health AI platform.
Femtech startup Cosm Medical is changing women’s pelvic health with a medical device that combines software, AI and 3D printing.
Femtech startup Cosm Medical is changing women’s pelvic health with a medical device that combines software, AI and 3D printing.
Discover how the SOPHIE program guided Epineuron Technologies’ efforts towards a pain-free future for people with peripheral nerve damage.
The EmergConnect platform is transforming access to healthcare for Canadians with support from the SOPHIE program.
The Molecules and Masterpieces event showcased the SOPHIE program’s role as a catalyst for partnerships, commercialization and innovation services in the Hamilton life science sector.
Innovation Factory announces an MOU with HaloHealth to deliver a collaborative medical assessment & physician advisory service to SOPHIE companies.
Hamilton region’s life science and health tech community driving economic prosperity HAMILTON, ON – November 8, 2022 – Yesterday, Innovation Factory welcomed the Honourable Filomena Tassi,
Southern Ontario Pharmaceutical & Health Innovation Ecosystem (SOPHIE) Program brings together Innovation Factory’s commercialization services with the Synapse Life Science Consortium’s strategic network to leverage access to Hamilton’s unique life sciences capabilities and research expertise.
